MLB: Police: Former Orioles P Brian Matusz likely died from overdose

Date:

Share post:


The cause of death of former Baltimore Orioles pitcher Brian Matusz likely is a drug overdose, The Baltimore Banner reported.

A report from the Phoenix Police Department, obtained by the publication, said Matusz was found dead in his home there on Jan. 6 with drug paraphernalia near his body and with a white substance in his mouth.

His mother found his body when she went to his home after being unable to reach him, per the report.

Matusz was 37.

The Orioles selected Matusz with the No. 4 overall pick in the 2008 draft. The left-hander posted a 27-41 record with a 4.85 ERA in 279 career games (68 starts) with the club.

“A staple in our clubhouse from 2009-16, Brian was beloved throughout Birdland, and his passion for baseball and our community was unmatched,” the Orioles said in a statement issued Jan. 7. “He dedicated his time to connecting with any fan he could, was a cherished teammate and always had a smile on his face.”

Matusz was traded to the Atlanta Braves in May 2016 but was released one week later. He joined the Chicago Cubs and pitched three innings against the Seattle Mariners on July 31, 2016, his final appearance.

–Field Level Media

spot_img

Related articles

MLB: Mariners trade for Cubs INF/OF Miles Mastrobuoni

The Seattle Mariners acquired utility player Miles Mastrobuoni from the Chicago Cubs on Tuesday for cash considerations. In a...

MLB: Reports: Japanese RHP Roki Sasaki rules out Yanks, Mets

Roki Sasaki's window to sign with a major league team opens Wednesday, but the coveted Japanese right-hander has...

MLB: Mariners sign INF Donovan Solano to one-year deal

The Seattle Mariners signed veteran infielder Donovan Solano to a one-year contract on Monday. According to a published report,...

MLB: Report: Ishbia brothers bought stake in White Sox as Twins bid looms

If Mat and Justin Ishbia want to purchase the Minnesota Twins, they'll first need to cut ties with...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.